The Economic Burden of Asthma in the United States, 2008‐2013

@article{Nurmagambetov2018TheEB,
  title={The Economic Burden of Asthma in the United States, 2008‐2013},
  author={Tursynbek A. Nurmagambetov and Robin Kuwahara and Paul L. Garbe},
  journal={Annals of the American Thoracic Society},
  year={2018},
  volume={15},
  pages={348–356}
}
Rationale: Asthma is a chronic disease that affects quality of life, productivity at work and school, and healthcare use; and it can result in death. [] Key Method For the main analysis, we applied two‐part regression models to estimate asthma‐related annual per‐person incremental medical costs and negative binomial models to estimate absenteeism associated with asthma. Results: Of 213,994 people in the pooled sample, 10,237 persons had treated asthma (prevalence, 4.8%).

Figures and Tables from this paper

Economic burden of asthma in India
  • P. Koul, R. Dhar
  • Medicine, Political Science
    Lung India : official organ of Indian Chest Society
  • 2018
TLDR
There is a substantial economic burden of the disease that varies from one country to the other; the determinants include Gross domestic product (GDP) of the country, Geographic and demographic status, and Organization of health services.
The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
TLDR
The burden of uncontrolled asthma will continue to grow for the next twenty years in the United States and strategies towards better management of asthma may be associated with substantial return on investment.
Estimating Lifetime Cost of Illness: An Application to Asthma.
TLDR
The economic burden of asthma is substantial and larger than previously estimated, reflecting expenditures on treatment and lost earnings.
Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States
TLDR
Asthma-related direct and indirect costs are significantly associated with asthma severity, with severe asthma medical costs being about three times higher than mild.
Asthma Surveillance — United States, 2006–2018
TLDR
Despite some improvements in asthma outcomes over time, the findings from this report indicate that disparities in asthma indicators persist by demographic characteristics, poverty level, and geographic location.
Direct and Indirect Costs of Asthma Burden in Abu Dhabi: A Retrospective Analysis of Insurance Claims Data from 2015 to 2018
TLDR
Asthma is a cause for huge expenditure from the health-care system perspective in Abu Dhabi and has a large impact on society through work absenteeism, which suggests a call-to-action to improve the disease management status using cost-effective strategies.
Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma
TLDR
The study demonstrates a clear relationship between asthma control and its impact on HRU, costs, work productivity and HRQoL, which will allow for better identification and management of patients with poorly controlled asthma.
The economic impact of asthma treatment on patients, 2014-2017: The Vietnamese experience from a public hospital.
TLDR
Asthma places a high economic burden on individuals and the healthcare system in Vietnam and the findings of this study provide health administrators with important evidence to enhance surveillance of the disease and to allow suitable drafting of national health policy.
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary Care
TLDR
There was evidence that the magnitude of socioeconomic disparities was elevated among older patients and those from ethnic minority groups and the impact of deprivation by age, sex, ethnicity, and treatment step was elevated.
An Overview of Health Disparities in Asthma
TLDR
In this overview, important factors associated with health disparities in asthma are highlighted and group these factors in five domains: biological, behavioral, socio-cultural, built environment, and health systems.
...
...

References

SHOWING 1-10 OF 63 REFERENCES
Costs of asthma in the United States: 2002-2007.
An economic evaluation of asthma in the United States.
TLDR
The distribution of health care resources used for asthma in the United States was studied in order to lay the groundwork for further policy decisions aimed at reducing the economic burden of this disorder.
The Economic Costs of Asthma
TLDR
It is believed that it would be possible to compare how various intervention strategies are likely to affect asthma costs and morbidity, thus providing a means for a more rational approach to healthcare policies regarding societal resource allocation for asthma.
The economic costs of asthma: a review and conceptual model.
TLDR
It is believed that it would be possible to compare how various intervention strategies are likely to affect asthma costs and morbidity, thus providing a means for a more rational approach to healthcare policies regarding societal resource allocation for asthma.
Incremental Direct Expenditure of Treating Asthma in the United States
  • S. Kamble, M. Bharmal
  • Medicine, Political Science
    The Journal of asthma : official journal of the Association for the Care of Asthma
  • 2009
TLDR
The prevalence of asthma among U.S. children and adults and its associated incremental expenditures, the annual direct medical expenditure attributable to asthma treatment is estimated at approximately $37.2 billion in 2007 U.s. dollars.
The health economics of asthma and rhinitis. I. Assessing the economic impact.
TLDR
This 2-part review examines the current health economic literature for asthma and rhinitis and explores how comparative studies have contributed to understanding how to best diagnose and treat asthma and allergic Rhinitis.
Socio‐economic burden of asthma, allergy, and other atopic illnesses
  • K. Weiss, S. Sullivan, K. Weiss
  • Medicine
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
  • 1994
TLDR
An overview of the different dimensions to the socio‐economic burden of asthma and other atopic diseases is provided and areas where future research in this area may advance the understanding of the impact of various treatment strategies of these diseases are suggested.
Medical cost burdens among nonelderly adults with asthma.
TLDR
It is found that those who were receiving treatment but continued to experience asthma attacks had the highest total and out-of-pocket expenditures in all categories, consistent with their likely higher illness severity.
...
...